VIDEO:
Many people live well with dementia. At the same time, misconceptions of the people they know and meet can make life harder than it has to be. See how the Alzheimer Society is looking to dispel these stigmas.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.
Until now, scientists were unsure about how APOE4 creates the strongest genetic risk factor in Alzheimer’s. Now they believe they know.
GENETICS & LIFESTYLE VIDEO: How do family history and genetics affect a healthy person’s risk of Alzheimer’s? Watch Harvard’s Top Alzheimer’s researcher, Dr. Rudy Tanzi, offer down-to-Earth insights.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On